Brief: TELA Bio Q3 Revenue USD 18.957 Million Vs. IBES Estimate USD 18.9 Million
07/11/2024 21:05
Nov 07 (Reuters) - TELA Bio Q3 income from operations USD -9.365 million. * Q3 net income USD -10.372 million * Q3 operating expenses USD 22.223 million * Q3 basic EPS USD -0.42 * Q3 gross profit USD 12.858 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants